Exact Mass: 419.0162148

Exact Mass Matches: 419.0162148

Found 11 metabolites which its exact mass value is equals to given mass value 419.0162148, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

   

(E)-3-(13,13-dibromotrideca-1,12-dienyl)-2H-azirine-2-carboxylic acid|motualevic acid F

(E)-3-(13,13-dibromotrideca-1,12-dienyl)-2H-azirine-2-carboxylic acid|motualevic acid F

C16H23Br2NO2 (419.0095418)


   

2-[(3-iodo-6-nitroindazol-1-yl)methoxy]ethyl-trimethylsilane

2-[(3-iodo-6-nitroindazol-1-yl)methoxy]ethyl-trimethylsilane

C13H18IN3O3Si (419.0162148)


   

Ethyl 6-bromo-5-hydroxy-1-methyl-2-(phenylsulfanylmethyl)indole-3-carboxylate

Ethyl 6-bromo-5-hydroxy-1-methyl-2-(phenylsulfanylmethyl)indole-3-carboxylate

C19H18BrNO3S (419.0190698)


   

iron(3+),tribenzoate

iron(3+),tribenzoate

C21H15FeO6 (419.021798)


   

(S)-5,5-Dioxo-9-((3,3,3-trifluoro-2-hydroxy-2-methylpropanoyl)amino)-4,10-dihydrothieno(3,2-C)(1)benzothiepin-10-one

(S)-5,5-Dioxo-9-((3,3,3-trifluoro-2-hydroxy-2-methylpropanoyl)amino)-4,10-dihydrothieno(3,2-C)(1)benzothiepin-10-one

C16H12F3NO5S2 (419.0108978)


   

Motualevic acid F

Motualevic acid F

C16H23Br2NO2 (419.0095418)


A 2H-azirine that is 2H-azirene-2-carboxylic acid substituted by a 13,13-dibromotrideca-1,12-dien-1-yl group at position 3 (the 2R stereoisomer). It is isolated from the marine sponge Siliquariaspongia sp. and exhibits antibacterial properties.

   

(Rac)-PT2399

(Rac)-PT2399

C17H10F5NO4S (419.0250680000001)


(Rac)-PT2399 (Compound 10e), the racemate of PT2399, acts as a potent and specific hypoxia-inducible factor 2a (HIF-2α) inhibitor with an IC50 of 0.01 μM[1].

   

PT2399

PT2399

C17H10F5NO4S (419.0250680000001)


PT2399 is a potent and selective HIF-2α antagonist, which directly binds to HIF-2α PAS B domain with an IC50 of 6 nM. PT2399 displays potent antitumor activity in vivo[1][2][3].

   

SDZ 220-040

SDZ 220-040

C16H16Cl2NO6P (419.00922660000003)


SDZ 220-040 is a competitive the mammalian NMDA receptor antagonist[1].